Ftse Mib
34.825,01
0,00%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
70.935,62
-0,72%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cingulate Inc (CING) Cingulate Inc (CING) Notizie

CING

Cingulate (CING)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CING
DataOraFonteTitoloSimboloCompagnia
08/05/202413:00GlobeNewswire Inc.Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business UpdateNASDAQ:CINGCingulate Inc
30/04/202411:45GlobeNewswire Inc.Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live AccessNASDAQ:CINGCingulate Inc
16/04/202423:00GlobeNewswire Inc.Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024NASDAQ:CINGCingulate Inc
01/04/202414:00GlobeNewswire Inc.Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business UpdateNASDAQ:CINGCingulate Inc
19/03/202421:45GlobeNewswire Inc.Cingulate to Participate in Benzinga All Live Access EventNASDAQ:CINGCingulate Inc
07/03/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
06/03/202412:45GlobeNewswire Inc.Cingulate to Attend DCAT Week 2024 in New York CityNASDAQ:CINGCingulate Inc
26/02/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGCingulate Inc
14/02/202423:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CINGCingulate Inc
13/02/202412:45GlobeNewswire Inc.Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of DirectorsNASDAQ:CINGCingulate Inc
09/02/202415:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CINGCingulate Inc
09/02/202412:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CINGCingulate Inc
06/02/202422:15GlobeNewswire Inc.Cingulate Announces Closing of $7.5 Million Public OfferingNASDAQ:CINGCingulate Inc
05/02/202423:00Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:CINGCingulate Inc
05/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CINGCingulate Inc
02/02/202415:15GlobeNewswire Inc.Cingulate Announces Pricing of $7.5 Million Public OfferingNASDAQ:CINGCingulate Inc
29/01/202414:59Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:CINGCingulate Inc
29/01/202414:00GlobeNewswire Inc.Longtime Cingulate Controller Jennifer Callahan Promoted to CFONASDAQ:CINGCingulate Inc
29/01/202412:45GlobeNewswire Inc.Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to MarketNASDAQ:CINGCingulate Inc
12/01/202423:03Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CINGCingulate Inc
06/12/202315:00Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:CINGCingulate Inc
01/12/202315:00GlobeNewswire Inc.Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)NASDAQ:CINGCingulate Inc
13/11/202322:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CINGCingulate Inc
13/11/202322:15GlobeNewswire Inc.Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business UpdateNASDAQ:CINGCingulate Inc
17/10/202320:22GlobeNewswire Inc.Cingulate to Host CNS Key Opinion Leader Panel in New York CityNASDAQ:CINGCingulate Inc
02/10/202322:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CINGCingulate Inc
22/09/202314:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CINGCingulate Inc
21/09/202319:30GlobeNewswire Inc.Cingulate Inc. to Present at the LD Micro Main Event XVINASDAQ:CINGCingulate Inc
13/09/202322:15GlobeNewswire Inc.Cingulate Announces Closing of $4.0 Million Public OfferingNASDAQ:CINGCingulate Inc
11/09/202315:22GlobeNewswire Inc.Cingulate Announces Pricing of $4.0 Million Public OfferingNASDAQ:CINGCingulate Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CING

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
TIT
Telecom Italia
BIT
BPSO
Banca Popolare di Sondrio
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
TITR
Telecom Italia
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network